Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.
第一作者:
Aditya,Juloori
第一单位:
Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois. Electronic address: ajuloori@radonc.uchicago.edu.
作者:
医学主题词
人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);肝肿瘤(Liver Neoplasms);前瞻性研究(Prospective Studies);免疫疗法(Immunotherapy);综合疗法(Combined Modality Therapy)
DOI
10.1016/j.ijrobp.2022.09.052
PMID
36108891
发布时间
2023-09-13
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



